The effects of magnesium and vitamin E co-supplementation on some cardiovascular ‎risk factors: A meta-analysis‏ ‏

Ghorbani Dehbalaei, Moazzameh and Asbaghi, Omid and Ashtary-Larky, Damoon and Amarpoor Mesrkanlou, Hossein (2020) The effects of magnesium and vitamin E co-supplementation on some cardiovascular ‎risk factors: A meta-analysis‏ ‏. Clinical Nutrition ESPEN.

Full text not available from this repository.

Abstract

Background Growing attention has been paid to use the combination of magnesium and vitamin E, which might ‎improve metabolic profiles in patients with metabolic diseases. Consequently, we conducted a meta-‎analysis of published randomized controlled trials (RCTs) to systematically analyze the effects of ‎magnesium and vitamin E co-supplementation on some cardiovascular risk factors in patients with ‎metabolic disorders.‎ Methods We searched the National Library of PubMed, Scopus, Web of Science, the Cochrane library and ‎Embase databases for studies published before February 2020 and included controlled trials in ‎which used mentioned intervention. Finally, we extracted 4 trials satisfying our selection criteria. ‎Two reviewers selected studies independently of each other and if they disagreed, was asked a ‎third reviewer. The risk of bias of individual studies was assessed using the Cochrane Collaboration ‎risk of bias tool. Data were pooled using the random-effects method and were expressed as ‎weighted mean difference (WMD) and 95% confidence intervals (CI).‎ Results A total of 4 studies meet the eligibility criteria. 119 individuals allocated to intervention and 118 ‎participants allocated to control group. Our meta-analysis indicated that the co-supplementation with ‎magnesium and vitamin E resulted in a significant decrease in FPG, Insulin, HOMA-IR, TG, TC, and ‎LDL-C in comparison with placebo. The co-supplementation with magnesium and vitamin E had no ‎significant effects on the body weight, BMI, and HDL. However, there were no significant ‎heterogeneity for all of the variables except for FPG (I 2 = 56.0%, P = 0.103) and TG (I 2 = 80.7%, ‎P = 0.006).‎ Conclusions Our meta-analysis indicated that the co-supplementation with magnesium and vitamin E resulted in a ‎significant decrease in FPG, Insulin, HOMA-IR, TG, LDL-C. Moreover, no significant effects on the ‎body weight, BMI and HDL were observed. However, the glycemic-improving properties of ‎magnesium and vitamin E co-supplementation were small and may not reach clinical importance‎

Item Type: Article
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: lorestan university
Date Deposited: 16 Dec 2020 06:46
Last Modified: 16 Dec 2020 06:46
URI: http://eprints.lums.ac.ir/id/eprint/2471

Actions (login required)

View Item View Item